This report contains market size and forecasts of Immunotherapy Drugs for Multiple Myeloma in Global, including the following market information:
Global Immunotherapy Drugs for Multiple Myeloma Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immunotherapy Drugs for Multiple Myeloma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
INF-α Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunotherapy Drugs for Multiple Myeloma include Tonghua Dongbao Pharmaceutical, Sumitomo , Merck, Biogen, Schering-Plough, Roche, Glaxo and Chiron, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunotherapy Drugs for Multiple Myeloma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunotherapy Drugs for Multiple Myeloma Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immunotherapy Drugs for Multiple Myeloma Market Segment Percentages, by Type, 2021 (%)
INF-α
IL-6
Rituximab
Other
Global Immunotherapy Drugs for Multiple Myeloma Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immunotherapy Drugs for Multiple Myeloma Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Center
Clinic
Other
Global Immunotherapy Drugs for Multiple Myeloma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immunotherapy Drugs for Multiple Myeloma Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunotherapy Drugs for Multiple Myeloma revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immunotherapy Drugs for Multiple Myeloma revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tonghua Dongbao Pharmaceutical
Sumitomo 
Merck
Biogen
Schering-Plough
Roche
Glaxo
Chiron